1. Market Research
  2. > Cancer Industry

Breast Cancer Industry, August 2016 Market Reports from Top Publishers

You might be interested in: Cancer, Therapy, Diagnostics, Biopsy, Cancer Diagnostic, Magnetic Resonance Imaging, Biosimilar, Hormone, Molecular Diagnostic, Oncology, Pharmaceutical, Antigen, Biomarker, Colorectal Cancer, DNA, Lung Cancer, Mammography Equipment, Computed Tomography, Fish, Immunotherapy.


 
1-10 of 99 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

Target Atlas in Breast Cancer: A Competitive Outlook

Target Atlas in Breast Cancer: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Breast Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in breast ...

Breast Cancer: Analytical Tool

Breast Cancer: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Breast Cancer Drug Pathway Analyzer

Breast Cancer Drug Pathway Analyzer

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 745 targeted molecular therapies known to affect more than 262 specific intracellular signaling pathways ...

Breast Cancer Drug Pipeline Update

Breast Cancer Drug Pipeline Update

  • $ 2 700
  • Company report
  • August 2016
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

 Hormone Refractory Breast Cancer-Pipeline Insights, 2016

Hormone Refractory Breast Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hormone Refractory Breast Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Refractory ...

Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis

Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis

  • $ 1 850
  • Industry report
  • July 2016
  • by Igate Research

Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development ...

Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023_United States

Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023_United States

  • $ 3 250
  • Industry report
  • July 2016
  • by Delve Insight

DelveInsight’s “Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023- US” Reports provides an overview of the disease and global market size of ...

Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016

Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016

  • $ 1 750
  • Industry report
  • July 2016
  • by Delve Insight

DelveInsight’s, “Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016

Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016

  • $ 2 450
  • Industry report
  • July 2016
  • by Delve Insight

DelveInsight’s, “Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016”, report provides comprehensive insights about the treatment landscape across this ...

Global Breast Cancer Partnering 2010 to 2016

Global Breast Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides comprehensive understanding and unprecedented access to breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms ...

About 13 000 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • January 2014
    186 pages
  • Therapy  

    Chemotherapy  

    Breast Cancer  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.